tissue microarray tma lvc1261 (Pantomics Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Pantomics Inc tissue microarray tma lvc1261
Tissue Microarray Tma Lvc1261, supplied by Pantomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tissue+microarray+format+(tma)/tissue+microarrays++lvc1261++containing+42+pairs+of+icc+specimens+and+corresponding+adjacent+non+cancerous+tissues/pm35924447-56-4-8
Average 90 stars, based on 1 article reviews

tissue microarray tma lvc1261 - by Bioz Stars, 2026-10

90/100 stars

Images

Microarray:

Article Title: DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01.
Article Snippet: .. Slides containing samples from tissue microarray (TMA) LVC1261 (Pantomics) were used for immunohistochemical analysis following the standard IHC protocol described above. ..

Article Title: RBM39 enhances cholangiocarcinoma growth through EZH2-mediated WNT7B/β-catenin pathway.
Article Snippet: .. The human CCA tissue microarray (Pantomics, LVC1261) was procured for the analysis of RBM39 expression. .. Following antigen retrieval, the tissue slides underwent incubation with primary antibodies targeting RBM39 (Proteintech, 21339-1-AP), EZH2 (Cell Signaling Technology, # 5246), non-phospho-β-catenin (Cell Signaling Technology, # 19807), cleaved Caspase-3 (Cell Signaling Technology, #9664) and KI67 (Proteintech, 27309-1-AP).

Article Title: RBM39 Enhances Cholangiocarcinoma Growth Through EZH2-mediated WNT7B/β-catenin Pathway
Article Snippet: .. The human CCA tissue microarray (Pantomics, LVC1261) was procured for the analysis of RBM39 expression. .. Following antigen retrieval, the tissue slides underwent incubation with primary antibodies targeting RBM39 (Proteintech, 21339-1-AP), EZH2 (Cell Signaling Technology, # 5246), non-phospho-β-catenin (Cell Signaling Technology, # 19807), cleaved Caspase-3 (Cell Signaling Technology, #9664), and KI67 (Proteintech, 27309-1-AP).

Immunohistochemical staining:

Immunohistochemistry:

Blocking Assay:

Article Title: WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Article Snippet: .. Tissue microarrays (TMAs)–tissue block LVC1261 were purchased from Pantomics. ..

Expressing:

Immunocytochemistry:

Article Title: Overexpression of proteasome 26S subunit non-ATPase 6 protein and its clinicopathological significance in intrahepatic cholangiocarcinoma
Article Snippet: .. Tissue microarrays (LVC1261) containing 42 pairs of ICC specimens and corresponding adjacent non-cancerous tissues were obtained from Pantomics, Inc. None of the tissue donor patients received any preoperative therapeutic interventions, and cholangiocarcinoma was the pathological type of all specimens. ..

other:

Article Title: WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Article Snippet: Tissue microarrays (TMAs)–tissue block LVC1261 were purchased from Pantomics. through the transcription of a broad panel of target genes that have been implicated in cell cycle transition, mitotic spindle assembly, and DNA segregation (57–61).

Review